196 related articles for article (PubMed ID: 37566414)
1. Integrating Opioid Use Disorder Treatment Into Primary Care Settings.
Austin EJ; Chen J; Briggs ES; Ferro L; Barry P; Heald A; Merrill JO; Curran GM; Saxon AJ; Fortney JC; Ratzliff AD; Williams EC
JAMA Netw Open; 2023 Aug; 6(8):e2328627. PubMed ID: 37566414
[TBL] [Abstract][Full Text] [Related]
2. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
[TBL] [Abstract][Full Text] [Related]
3. Race and Ethnicity and Prehospital Use of Opioid or Ketamine Analgesia in Acute Traumatic Injury.
Brunson DC; Miller KA; Matheson LW; Carrillo E
JAMA Netw Open; 2023 Oct; 6(10):e2338070. PubMed ID: 37847499
[TBL] [Abstract][Full Text] [Related]
4. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
Mauro PM; Gutkind S; Annunziato EM; Samples H
JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
[TBL] [Abstract][Full Text] [Related]
5. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
6. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
Miele K; Kim SY; Jones R; Rembert JH; Wachman EM; Shrestha H; Henninger ML; Kimes TM; Schneider PD; Sivaloganathan V; Sward KA; Deshmukh VG; Sanjuan PM; Maxwell JR; Seligman NS; Caveglia S; Louis JM; Wright T; Bennett CC; Green C; George N; Gosdin L; Tran EL; Meaney-Delman D; Gilboa SM
MMWR Surveill Summ; 2023 May; 72(3):1-14. PubMed ID: 37130060
[TBL] [Abstract][Full Text] [Related]
7. Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder.
Bulgin D; Patrick SW; McElroy T; McNeer E; Dupont WD; Murry VM
Obstet Gynecol; 2023 Aug; 142(2):339-349. PubMed ID: 37473410
[TBL] [Abstract][Full Text] [Related]
8. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
[TBL] [Abstract][Full Text] [Related]
9. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
Wartko PD; Bobb JF; Boudreau DM; Matthews AG; McCormack J; Lee AK; Qiu H; Yu O; Hyun N; Idu AE; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Labelle CT; Zare-Mehrjerdi M; Stotts AL; Braciszewski JM; Murphy MT; Dryden D; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Phillips RC; Shea M; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Lapham GT; Addis M; Bradley KA; ; Ghiroli MM; Hamilton LK; Hu Y; LaHue JS; Loree AM; Murphy SM; Northrup TF; Shmueli-Blumberg D; Silva AJ; Weinstein ZM; Wong MT; Burganowski RP
JAMA Intern Med; 2023 Dec; 183(12):1343-1354. PubMed ID: 37902748
[TBL] [Abstract][Full Text] [Related]
10. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
11. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.
Gustavson AM; Kenny ME; Wisdom JP; Salameh HA; Ackland PE; Gordon AJ; Hagedorn HJ
Addict Sci Clin Pract; 2021 Aug; 16(1):51. PubMed ID: 34362445
[TBL] [Abstract][Full Text] [Related]
12. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics.
Austin EJ; Briggs ES; Ferro L; Barry P; Heald A; Curran GM; Saxon AJ; Fortney J; Ratzliff AD; Williams EC
J Gen Intern Med; 2023 Feb; 38(2):332-340. PubMed ID: 35614169
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.
Rasmussen KM; Patil V; Li C; Yong C; Appukkuttan S; Grossman JP; Jhaveri J; Halwani AS
JAMA Netw Open; 2023 Oct; 6(10):e2337272. PubMed ID: 37819658
[TBL] [Abstract][Full Text] [Related]
14. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care.
Chang ET; Oberman RS; Cohen AN; Taylor SL; Gumm E; Mardian AS; Toy S; Revote A; Lewkowitz B; Yano EM
J Gen Intern Med; 2020 Dec; 35(Suppl 3):918-926. PubMed ID: 33145686
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
[TBL] [Abstract][Full Text] [Related]
16. Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits.
Coley RY; Johnson E; Simon GE; Cruz M; Shortreed SM
JAMA Psychiatry; 2021 Jul; 78(7):726-734. PubMed ID: 33909019
[TBL] [Abstract][Full Text] [Related]
17. "The Only Reason I Am Willing to Do It at All": Evaluation of VA's SUpporting Primary care Providers in Opioid Risk reduction and Treatment (SUPPORT) Center.
Williams EC; Frost MC; Danner AN; Lott AMK; Achtmeyer CE; Hood CL; Malte CA; Saxon AJ; Hawkins EJ
J Addict Med; 2024 May-Jun 01; 18(3):248-255. PubMed ID: 38385548
[TBL] [Abstract][Full Text] [Related]
18. Expanding access to medications for opioid use disorder through locally-initiated implementation.
Wyse JJ; Mackey K; Lovejoy TI; Kansagara D; Tuepker A; Gordon AJ; Todd Korthuis P; Herreid-O'Neill A; Williams B; Morasco BJ
Addict Sci Clin Pract; 2022 Jun; 17(1):32. PubMed ID: 35725648
[TBL] [Abstract][Full Text] [Related]
19. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.
Chen T; Kharazmi E; Fallah M
JAMA Netw Open; 2023 Apr; 6(4):e238893. PubMed ID: 37074714
[TBL] [Abstract][Full Text] [Related]
20. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
